VON WILLEBRAND
Clinical evaluation of the Sebia Hydragel von Willebrand factor assay in comparison to Electrophoresis and blotting based Multimer analysis
Seidel H, Westhofen P, Bautista H, Beaulieu G, Nouadje G, Kruppenbacher JP
Centrum für Blutgerinnungsstörungen und Transfusionsmedizin, Bonn / Research & Development, Sebia, Lisses, France
ISTH 2017
Performances of the Hydragel 5 von Willebrand multimers- a new within-day von Willebrand factor (VWF) multimer screening method
Bowyer AE, Goodfellow KJ, Nouadje G, Beaulieu G, Stufano F, Kitchen S, Makris M
Sheffield Haemophilia and Thrombosis Centre, UK / Angelo Bianchi Bonomi' Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore, Policlinico and Luigi Villa Foundation, Milan, Italy / Research & Development Sebia, Lisses, France
ISTH 2017
Evaluation of a new commercial method for von Willebrand Factor multimeric analysis
Crist RA, Heikal NM, Rodgers GM, Grenache D, Kunzel TM, Choi MA, Smock KJ
ARUP Laboratories Institute for Clinical and Experimental Pathology, Salt Lake City, UT / Departments of Pathology and Internal Medicine, University of Utah Health Sciences Center, Salt Lake City, UT, United States
ISLH 2017
Clinical interest of same-day results assay “ Hydragel 5 von Willebrand Multimers ”
Vasse M, Francois D, Bironien R, Nouadje G
Clinical Biology, Hôpital Foch, Suresnes / Research & Development, Sebia, Lisses, France
IFCC 2017
Assessment of biological response to desmopressin using von Willebrand factor Multimers analysis
Pikta M, Saks K, Lepik K, Zemtsovskaja G, Villemson K, Bautista H, Nouadje G, Viigimaa M, Banys V
North Estonia Medical Centre, Laboratory, Tallinn, Estonia / Tallinn University of Technology, School of Information Technologies, Department of Health Technologies, Tallinn, Estonia / Tallinn Children`s Hospital, Hematology Department, Tallinn, Estonia / Mediq Estonia OÜ / Vilnius University, Faculty of Medicine, Department of Physiology, Biochemistry, Microbiology and Laboratory Medicine, Vilnius, Lithuania / Research & Development Sebia, Lisses, France
IFCC 2017 & ISTH 2017
Clinical evaluation of the Hydragel 5 von Willebrand Multimers of Sebia
Lemaitre A, Nouadje G, Beaulieu Bautista H, Desmet S, Gavard C, Eeckhoudt S
Cliniques universitaires Saint Luc, Brussels, Belgium / Research & Development Sebia, Lisses, France
IFCC 2017 & ISTH 2017
Sebia Hydragel 5 von Willebrand Multimers - A new and rapid von Willebrand factor (VWF) multimer screening method to aid subtyping of type 2 von Willebrand disease (VWD)
Goodfellow KJ, Bowyer AE, Nouadje G, Beaulieu G, Kitchen S, Makris M
Sheffield Haemophilia and Thrombosis Centre, UK / Research & Development Sebia, Lisses, France
IFCC 2017
EVALUATION OF THE SEBIA HYDRAGEL 5 VON WILLEBRAND FACTOR (VWF) ASSAY WITH AN IN-HOUSE AGAROSE GEL ELECTROPHORESIS METHOD FOR VWF MULTIMER ANALYSIS
Goodfellow KJ, Bowyer AE, Nouadje G, Beaulieu G, Kitchen S, Makris M
Sheffield Haemophilia and Thrombosis Centre, UK / Research & Development Sebia, Lisses, France
WHF 2016
INTEREST OF THE NEW RAPID TEST “HYDRAGEL 5 VON WILLEBRAND MULTIMERS” FOR THE ANALYSIS OF VON WILLEBRAND MULTIMERS
Nouadje G, Francois D, Ligneel T, Bironien R, Beaulieu G, Vasse M
Clinical Biology, Hôpital Foch, Suresnes / Research & Development, Sebia, Lisses, France
ISLH 2016
INDUSTRIAL DEVELOPMENT OF A WITHIN-DAY VON WILLEBRAND FACTOR MULTIMERS ASSAY USING AGAROSE GEL ELECTROPHORESIS
Ligneel T, Beaulieu G, Nouadje G
Research & Development, Sebia, Lisses, France
IFCC 2015
INTEREST OF A NEW RAPID COMMERCIAL ASSAY FOR THE ANALYSIS OF VON WILLEBRAND MULTIMERS IN AGAROSE GEL
Nouadje G, Francois D, Ligneel T, Bironien R, Beaulieu G, Vasse M
Clinical Biology, Hôpital Foch, Suresnes / Research & Development, Sebia, Lisses, France
EHA 2015
